Sarcoidosis: Difference between revisions

 
(5 intermediate revisions by 3 users not shown)
Line 4: Line 4:
**Exact cause unknown - thought to be related to an immune reaction to a prior insult such as infection or chemical exposure earlier in life.
**Exact cause unknown - thought to be related to an immune reaction to a prior insult such as infection or chemical exposure earlier in life.
**Do not confuse with infectious granulomatous processes such as [[tuberculosis]].
**Do not confuse with infectious granulomatous processes such as [[tuberculosis]].
[[File:SarcoidXray.png|thumb|Sarcoid Xray - hilar adenopathy]]


==Clinical Features==
==Clinical Features==
[[File:PMC3505767 ad-24-383-g009.png|thumb|Sarcoidosis. (A) Subcutaneous nodules without changes in overlying epidermis. (B) Characteristic non-caseating granuloma with giant cell.]]
[[File:Lupus_pernio.jpg|thumb|Lupus pernio is pathognomonic for sarcoidosis]]
''Depend on location of granulomata. May be entirely asymptomatic.''
''Depend on location of granulomata. May be entirely asymptomatic.''
*Respiratory
*Respiratory
Line 14: Line 14:
**[[Cough]]
**[[Cough]]
**[[Pulmonary hypertension]]
**[[Pulmonary hypertension]]
**Pulmonary abscesses/[[empyema]]
**[[lung abscess|Pulmonary abscesses]]/[[empyema]]
**[[Pneumothorax]]
**[[Pneumothorax]]
*Erythema nodosum and other skin lesions
*[[Erythema nodosum]] and other skin lesions
**[[Lupus pernio]] is pathognomonic for sarcoidosis and the most specific physical exam finding<ref>James WD, Berger TG, Elston DM. Macrophage/Monocyte Disorders. In: James WD, Berger TG, Elston DM (eds). Andrews’ Diseases of the Skin, 12e. Philadelphia, PA: Elsevier; 2016, Chapter 31.</ref>
*Fatigue
*Fatigue
*Weight loss
*Weight loss
*Arthralgias
*[[Arthralgia]]s
*Cardiopulmonary
*Cardiopulmonary
**[[Restrictive cardiomyopathy]]
**[[Restrictive cardiomyopathy]]
**Arrythmias due to conduction disturbance
**[[Arrhythmias]] due to conduction disturbance
*Endocrine
*Endocrine
**[[Hypercalcemia]]
**[[Hypercalcemia]]
Line 28: Line 29:
**[[Adrenal insufficiency]]
**[[Adrenal insufficiency]]
*Ocular
*Ocular
**Dacryoadenitis (lacrimal duct inflammation)
**[[Dacryoadenitis]] (lacrimal duct inflammation)
**Optic neuritis
**[[Optic neuritis]]
**Iritis
**[[Iritis]]
 


==Differential Diagnosis==
==Differential Diagnosis==
Line 41: Line 41:
*[[Churg-Strauss syndrome]]
*[[Churg-Strauss syndrome]]
*[[Lupus]]
*[[Lupus]]
*Rheumatoid arthritis
*[[Rheumatoid arthritis]]
*Polymyalgia rheumatica
*[[Polymyalgia rheumatica]]
 
==Workup==


==Evaluation==
[[File:SarcoidXray.png|thumb|Sarcoid Xray - hilar adenopathy]]
*Definitive initial diagnosis unlikely to be made in ED, but may be suggested by typical granulomatous lesions seen on CT or other imaging in setting of appropriate clinical context
*Evaluate for complications/alternative diagnoses of presenting symptoms


==Management==
==Management==
 
*[[Corticosteroids]]
*Treat complications


==Disposition==
==Disposition==
 
*Dependent on presentation


==See Also==
==See Also==

Latest revision as of 20:25, 1 February 2021

Background

  • Abnormal collection of inflammatory cells (granulomas) throughout the body.
    • Most common location for granulomas to occur are the lung, skin, heart, and brain.
    • Exact cause unknown - thought to be related to an immune reaction to a prior insult such as infection or chemical exposure earlier in life.
    • Do not confuse with infectious granulomatous processes such as tuberculosis.

Clinical Features

Sarcoidosis. (A) Subcutaneous nodules without changes in overlying epidermis. (B) Characteristic non-caseating granuloma with giant cell.
Lupus pernio is pathognomonic for sarcoidosis

Depend on location of granulomata. May be entirely asymptomatic.

Differential Diagnosis

Evaluation

Sarcoid Xray - hilar adenopathy
  • Definitive initial diagnosis unlikely to be made in ED, but may be suggested by typical granulomatous lesions seen on CT or other imaging in setting of appropriate clinical context
  • Evaluate for complications/alternative diagnoses of presenting symptoms

Management

Disposition

  • Dependent on presentation

See Also

External Links

References

  1. James WD, Berger TG, Elston DM. Macrophage/Monocyte Disorders. In: James WD, Berger TG, Elston DM (eds). Andrews’ Diseases of the Skin, 12e. Philadelphia, PA: Elsevier; 2016, Chapter 31.